We are live on
!
Find out more
LC
Lindbrook Capital Portfolio holdings
AUM
$1.08B
1-Year Est. Return
10.14%
This Fund
S&P 500
This Quarter
Est. Return
-2.38%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
–
AUM
$894M
AUM Growth
-$45.6M
(-4.8%)
Cap. Flow
-$16.9M
Cap. Flow
% of AUM
-1.9%
Top 10 Holdings %
Top 10 Hldgs %
46.04%
Holding
2,887
New
179
Increased
1,150
Reduced
723
Closed
200
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$1.09M |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.05M |
| 3 |
Vanguard Morningstar Value ETF
VTV
|
+$998K |
| 4 |
Oneok
OKE
|
+$877K |
| 5 |
Kinder Morgan
KMI
|
+$786K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oaktree Specialty Lending
OCSL
|
+$7.4M |
| 2 |
NovoCure
NVCR
|
+$2.21M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$1.87M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.62M |
| 5 |
NVIDIA
NVDA
|
+$1.52M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.87% |
| 2 | Technology | 14.74% |
| 3 | Healthcare | 5.91% |
| 4 | Consumer Discretionary | 3.51% |
| 5 | Industrials | 3.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1876
Agios Pharmaceuticals
AGIO
$1.93B
| $3.89K | ﹤0.01% |
157
-74
| -32% | -$1.96K |
|
1877
StoneX
SNEX
$7.94B
| $3.88K | ﹤0.01% |
203
-20
| -9% | -$367 |
|
1878
Steven Madden
SHOO
$3.55B
| $3.88K | ﹤0.01% |
122
| – | – |
|
|
LKFT
1879
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.77B
| $3.87K | ﹤0.01% |
112
-5
| -4% | -$195 |
|
1880
Vertiv
VRT
$105B
| $3.87K | ﹤0.01% |
104
+8
| +8% | +$264 |
|
1881
First Financial Bancorp
FFBC
$3.53B
| $3.86K | ﹤0.01% |
197
| – | – |
|
1882
Walker & Dunlop
WD
$1.53B
| $3.86K | ﹤0.01% |
52
+9
| +21% | +$761 |
|
1883
AbCellera Biologics
ABCL
$2.12B
| $3.85K | ﹤0.01% |
836
+779
| +1,367% | +$4.74K |
|
|
FSR
1884
DELISTED
Fisker Inc.
FSR
| $3.85K | ﹤0.01% |
599
+153
| +34% | +$930 |
|
|
OPRA
1885
Opera Ltd
OPRA
$1.79B
| $3.84K | ﹤0.01% |
341
+46
| +16% | +$770 |
|
1886
First Bancorp
FBNC
$2.68B
| $3.83K | ﹤0.01% |
136
| – | – |
|
1887
Tompkins Financial
TMP
$1.42B
| $3.82K | ﹤0.01% |
78
+55
| +239% | +$2.98K |
|
1888
International Bancshares
IBOC
$4.57B
| $3.81K | ﹤0.01% |
88
-214
| -71% | -$9.79K |
|
1889
Pulmonx
LUNG
$87.6M
| $3.81K | ﹤0.01% |
369
| – | – |
|
1890
GATX Corp
GATX
$6.27B
| $3.81K | ﹤0.01% |
35
| – | – |
|
1891
Constellium
CSTM
$3.99B
| $3.8K | ﹤0.01% |
209
| – | – |
|
1892
OGE Energy
OGE
$9.71B
| $3.8K | ﹤0.01% |
114
+39
| +52% | +$1.37K |
|
1893
Virtu Financial
VIRT
$4.93B
| $3.8K | ﹤0.01% |
220
-475
| -68% | -$8.63K |
|
1894
Barrett Business Services
BBSI
$804M
| $3.79K | ﹤0.01% |
168
| – | – |
|
1895
Avis
CAR
$5.02B
| $3.77K | ﹤0.01% |
21
+3
| +17% | +$650 |
|
1896
Celestica
CLS
$36.5B
| $3.75K | ﹤0.01% |
153
| – | – |
|
1897
Rocket Pharmaceuticals
RCKT
$394M
| $3.75K | ﹤0.01% |
183
+95
| +108% | +$1.73K |
|
1898
LiveRamp
RAMP
$2.3B
| $3.75K | ﹤0.01% |
130
+17
| +15% | +$502 |
|
1899
Medifast
MED
$141M
| $3.74K | ﹤0.01% |
50
-58
| -54% | -$5.15K |
|
1900
Badger Meter
BMI
$4.03B
| $3.74K | ﹤0.01% |
26
| – | – |
|
Similar funds
SBIA
CHP
MW
TAM
SIA
CIG
CCM
WCF
Lindbrook Capital's Q3 2023 Portfolio in Review
As of Q3 2023, Lindbrook Capital held 2,887 positions worth $894M, down 4.8% from $939M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Lindbrook Capital's Q3 2023 filing shows 179 new, 1,150 increased, 723 reduced and 200 closed positions. Its largest new stake was NuStar Energy L.P.: 17,923 shares worth $313K. The largest sale was Oaktree Specialty Lending, an estimated $7.4M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.
- Lindbrook Capital's largest Q3 2023 buy was NuStar Energy L.P.: 17,923 shares worth $313K.
- Lindbrook Capital added most to Vanguard Morningstar Total Stock Market ETF in Q3 2023, an estimated $1.09M increase.
- Lindbrook Capital's biggest Q3 2023 reduction was Oaktree Specialty Lending, cutting an estimated $7.4M.
- Lindbrook Capital fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $912K.
- Lindbrook Capital's ten largest holdings make up 46% of its $894M portfolio in Q3 2023.
- Lindbrook Capital opened 179 new positions and closed 200 in Q3 2023.
- Lindbrook Capital's portfolio value fell 4.8% quarter-over-quarter to $894M.
Based on Lindbrook Capital's 13F filing for Q3 2023, filed 25 Oct 2023.